A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk

A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk

Andrea Manfrin,1 Valentina Trimarco,2,3 Maria Virginia Manzi,2,4 Francesco Rozza,2,4 Raffaele Izzo2,5 1Sussex Pharmacy, School of Life Sciences, University of Sussex, Falmer, Brighton, UK; 2Hypertension Research Centre, University of Naples Federico II, Naples, Italy; 3Department o...

Full description

Bibliographic Details
Main Authors: Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Hypercholesterolemia
Nutraceuticals
Effectiveness
Cardiovascular risk reduction
Online Access:https://www.dovepress.com/a-single-blind-multicenter-randomized-controlled-trial-to-evaluate-the-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/a-single-blind-multicenter-randomized-controlled-trial-to-evaluate-the-peer-reviewed-article-CEOR

Similar Items